Yazar "Hatipoglu, S." seçeneğine göre listele

Listeleniyor 1 - 5 / 5
  • Küçük Resim Yok
    Öğe
    Liver Transplantation following Blunt Liver Trauma
    (Elsevier Science Inc, 2012) Hatipoglu, S.; Bulbuloglu, E.; Ates, M.; Kayaalp, C.; Yilmaz, S.
    Due to developing medical technology worldwide, an increasing number of liver transplantations are performed for various indications. Liver transplantation has a limited but important role in specific life-threatening liver trauma cases, when initial therapeutic options fail to control the bleeding or when liver failure ensues. Herein we have reported a patient who required liver transplantation at 18 days after blunt liver trauma with acute liver failure. This case report suggested that liver transplantation is a potential treatment modality for a selected group of patients including pedratric cases who experience acute or subacute liver failure secondary to blunt trauma.
  • Küçük Resim Yok
    Öğe
    Living Donor Liver Transplantation for Alveolar Echinococcus Is a Difficult Procedure
    (Elsevier Science Inc, 2013) Hatipoglu, S.; Bulbuloglu, B.; Piskin, T.; Kayaalp, C.; Yilmaz, S.
    Surgical resection is the best treatment for early stage alveolar echinococcosis of the liver. In the stages that are not appropriate for resection and when the case develops complications, a liver transplant can be a lifesaver. The liver transplants of alveolar echinococcosis are technically difficult because of prior operation, interventional radiological procedures, and large mass. Despite such difficulty, living donor liver transplantation can save one's life.
  • Küçük Resim Yok
    Öğe
    Living Donor Liver Transplantation in the Absence of Inferior Vena Cava: A Case Report
    (Elsevier Science Inc, 2012) Hatipoglu, S.; Olmez, A.; Ozgor, D.; Kayaalp, C.; Yilmaz, S.
    Because of difficulties in the supply of cadaveric organs, of living donor liver transplantations are performed in increasing numbers. Congenital hepatic fibrosis associated with fibrosis and atrophy of the inferior vena cava were present in a potential recipient of living donor liver transplantation. This case report documented living donor liver transplantation as a treatment modality for a patient with absence of the inferior vena cava due to chronic liver failure.
  • Küçük Resim Yok
    Öğe
    Right Lobe Living Donor Liver Transplantation for Adult Patients with Acute Liver Failure: A Single-Center Experience in Turkey
    (Lippincott Williams & Wilkins, 2012) Ates, M.; Dirican, A.; Hatipoglu, S.; Ince, V; Isik, B.; Yilmaz, M.; Cemallettin, A.
    [Abstract Not Available]
  • Küçük Resim Yok
    Öğe
    Right-Lobe Living-Donor Liver Transplantation in Adult Patients With Acute Liver Failure
    (Elsevier Science Inc, 2013) Ates, M.; Hatipoglu, S.; Dirican, A.; Isik, B.; Ince, V.; Yilmaz, M.; Aydin, C.
    Background. Right-lobe living-donor liver transplantation (RLDLT) is an excellent option to reduce donor shortages for adult patients with acute liver failure (ALF). The aim of this study was to evaluate the etiologies and outcomes of 30 consecutive adult patients who underwent emergency RLDLT for ALP. Methods. Between January 2007 and September 2011, we examined data from medical records of patients with ALF who underwent RLDLT. Results. Their mean age was 32.2 +/- 13.05 years. The etiologies of ALP were acute hepatitis B (n = 11; 36.6%), hepatitis A (n = 4; 13.3%), drug intoxication (n = 4; 13.3%), pregnancy (n = 2; 6.7%), hepatitis B with pregnancy (n = 1; 3.3%), mushroom intoxication (n = 1; 3.3%), and unknown (n = 7; 23.3%). The mean hepatic coma grade (Model for End-Stage Liver Disease score) was 34.13 +/- 8.72. The 43 (48.7%) postoperative complications were minor (grades I-II) and 44 (51.3%) were major (grades III-V). Reoperation was required in 14 of 30 (47%) recipients (grades IIIb-IVa). Deaths occurred owing to pulmonary (n = 2), cardiac (n = 1), septic (n = 2), or encephalopathic (n = 4) complications. The mean durations of intensive care unit stay and postoperative hospitalization were 3.2 +/- 2.3 and 29.5 +/- 23 days, respectively. The survival rate was 70%. The mean follow-up duration was 305 days (range, 1-1582). Conclusion. Liver transplantation is potentially the only curative modality, markedly improving the prognosis of patients with ALP. The interval between ALF onset and death is short and crucial because of the rapid, progressive multiorgan failure. Thus, RLDLT should be considered to be a life-saving procedure for adult patients with ALF, requiring quicker access to a deceased-donor liver graft and a short ischemia time.